The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Anthelmintic Drugs Market During 2026–2030?
The anthelmintic drugs market has demonstrated robust growth recently. Projections indicate a rise from $3.34 billion in 2025 to $3.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.5%. Historically, this expansion has been driven by factors such as the significant prevalence of parasitic infections, restricted availability of advanced anthelmintic drugs, continued dependence on traditional drug classes, increased understanding of helminth infections, and the development of hospital and clinic infrastructure.
The anthelmintic drugs market size is anticipated to experience substantial growth over the coming years. This market is projected to reach $4.32 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. The expansion during this forecast period stems from factors such as the creation of new anthelmintic compounds, a greater uptake of combination therapies, an increase in veterinary and livestock uses, the widening reach of online and retail pharmacy channels, and government-led initiatives for parasite control programs. Key trends anticipated in the forecast duration involve a rising occurrence of helminth infections in both humans and animals, the increasing acceptance of oral anthelmintics and injectable formulations, a growing need for veterinary anthelmintics in managing livestock, the broadening of retail and online pharmacy outlets for anthelmintic drugs, and an emphasis on combination therapies and broad-spectrum anthelmintics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp
What Underlying Factors Are Accelerating The Growth Of The Anthelmintic Drugs Market?
The increasing incidence of parasitic infections is anticipated to boost the expansion of the anthelmintic drugs market in the future. These infections are illnesses resulting from organisms like protozoa, worms, or ectoparasites residing within or on another host. Factors contributing to parasitic infections include substandard sanitation, tainted food or water, proximity to infected humans or animals, insufficient hygiene, and limited availability of clean resources. Anthelmintic medications are utilized for managing infections brought on by parasitic worms, efficiently targeting and removing them from the host’s system. These drugs operate by interfering with the parasites’ normal physiological processes, resulting in their expulsion or demise. For example, reports from the Centers for Disease Control and Prevention (a US-based national public health agency) indicated that by September 16, 2025, a total of 990 cases of cyclosporiasis acquired within the United States had been reported to the CDC in September 2025. Consequently, the widespread occurrence of parasitic infections is stimulating the growth of the anthelmintic drugs market.
How Are The Various Segments Of The Anthelmintic Drugs Market Categorized?
The anthelmintic drugs market covered in this report is segmented –
1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections
4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics, Veterinary Anthelmintics
Subsegments:
1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole
2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime
3) By Pyrazinoisoquinolones: Praziquantel, Cysticide
4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate
5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals
What Trends Are Affecting The Expansion Of The Anthelmintic Drugs Market?
Leading companies within the anthelmintic drugs market are prioritizing the creation of advanced strategies, such as focused, data-driven deworming initiatives. This shift aims to enhance parasite management, mitigate drug resistance development, and ensure the lasting effectiveness of anthelmintics, contrasting sharply with conventional, widespread deworming methods that often involve regular, non-specific treatments. These precise deworming programs utilize diagnostic evaluations, assessments of parasite burden, and carefully planned dosing regimens. This approach maximizes treatment effectiveness while concurrently diminishing environmental concerns and the potential for resistance. An illustrative example is Zoetis Inc., a US-based animal health company, which introduced its “Buy Less Dewormer” campaign in April 2025. This initiative, aimed at equine populations, advocates for parasite management grounded in scientific evidence. The campaign integrates learning materials with advice on monitoring fecal egg counts and making informed choices for anthelmintic drugs. Its operation encourages horse owners and veterinary professionals to give treatments only when essential, guided by the level of parasite infestation and risk evaluations. Distinctive aspects encompass comprehensive educational content, recommendations for treatment based on risk, and fostering responsible anthelmintic use. Its utility extends to managing equine herd health, preventing the development of parasite resistance, and refining deworming timetables. Advantages encompass decreased excessive use of anthelmintics, better results in parasite control, reduced expenses for horse owners, and the fostering of enduring drug effectiveness.
Which Major Firms Influence Developments In The Anthelmintic Drugs Market?
Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company
Read the full anthelmintic drugs market report here:
https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report
Which Region Is Projected To Dominate The Anthelmintic Drugs Market During The Forecast Period?
North America was the largest region in the anthelmintic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Anthelmintic Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19291&type=smp
Browse Through More Reports Similar to the Global Anthelmintic Drugs Market 2026, By The Business Research Company
Kidney Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report
Prostate Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Ovarian Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model